14 In total, 383 of 1, 583 BRCA1 mutation carriers and 454 of 881 BRCA2 mutation carriers took tamoxifen after being diagnosed with breast cancer <a href=http://stromectol.autos/>stromectol for sale</a> In a European trial that evaluated lipid profiles following raloxifene therapy over the 24 month period, there were significant decreases in the serum concentrations of total and low density lipoprotein LDL cholesterol over a 24 month period of raloxifene therapy